RA
Raffles Medical Group Ltd
RAFLF · OTC
$0.64 +0.00% (+$0.00)
1M -4.78%
Market Cap $1.51B
P/E Ratio 22.35x
Div. Yield 3.67%
ROE 6.42%
Bulios Fair Price
$0.89
39.1% upside
Current Price
$0.64
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RAFLF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
72 /100
Cheap P/E 22.35x
EV/EBITDA 11.27x
P/S 2.04x
Growth
6 /100
Declining EPS growth 20.87%
Rev. growth 2.41%
FCF growth 16.91%
Profitability
69 /100
Strong Gross margin 44.35%
Net margin 9.12%
Op. margin 11.73%
Quality
35 /100
Average ROIC 6.10%
ROE 6.42%
ROA 4.88%
Debt
92 /100
Low Debt/Equity 0.03x
Current ratio 1.30x
Net debt/EBITDA -2.01x
Stability
63 /100
Moderate Beta 0.21x
Rev. volatility 10.57%
EPS volatility 27.96%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RAFLF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Choon Yong Loo
Employees
2,965
Headquarters
Singapore
Upcoming events
22 FEB
Earnings
Upcoming earnings report